Johnson & Johnson is primarily active in the healthcare industry. With a diverse range of products, the company operates in multiple sectors such as pharmaceuticals, medical devices, and consumer health. Johnson & Johnson is renowned for its comprehensive portfolio that includes prescription drugs, over-the-counter medications, surgical equipment, contact lenses, and personal care products. Being a global leader, Johnson & Johnson's presence extends across various healthcare segments, enabling it to contribute significantly to advancing medical solutions and enhancing overall well-being.

Some of the main competitors of Johnson & Johnson in the market include Pfizer Inc., Merck & Co., Inc., and Roche Holding AG.

Johnson & Johnson is a multinational healthcare company that was founded in 1886. It has a rich history and has become a leader in the pharmaceutical, medical devices, and consumer healthcare sectors. With over 130 years of experience, Johnson & Johnson has continually focused on delivering innovative solutions to improve the health and well-being of people around the world. The company has grown through strategic acquisitions and partnerships, expanding its product portfolio and global presence. Johnson & Johnson's commitment to research and development, along with its dedication to ethical business practices, have made it a trusted name in the healthcare industry.

Some significant milestones achieved by Johnson & Johnson include the development of innovative medical treatments and breakthrough pharmaceutical products. Throughout its history, the company has also played a crucial role in the advancement of healthcare technology and the improvement of patient care. Johnson & Johnson has consistently demonstrated its commitment to quality and safety, earning a reputation as a trusted global healthcare leader. With a strong focus on research and development, the company has introduced numerous life-saving and life-enhancing solutions to address a wide range of medical needs. Through its dedication to innovation and excellence, Johnson & Johnson continues to shape the future of healthcare.

Johnson & Johnson is primarily present in several countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered, and it operates in countries across North America, Europe, Asia Pacific, and Latin America. Some prominent regions where Johnson & Johnson operates include Canada, Germany, France, Japan, Australia, Brazil, and China. With its diverse portfolio of healthcare products and services, Johnson & Johnson continues to expand its presence globally, serving the healthcare needs of people in numerous countries and regions.

Johnson & Johnson is a renowned global healthcare company that upholds strong values and a clear corporate philosophy. With a commitment to improving the well-being of people worldwide, the company focuses on three fundamental principles: caring for the world, keeping customers at the center, and cherishing employees. Johnson & Johnson values integrity, innovation, diversity, and collaboration, consistently striving to deliver high-quality products and solutions. With a customer-centric approach, the company endeavors to create lasting relationships and enhance experiences. By fostering a supportive work environment and promoting professional growth, Johnson & Johnson ensures its employees play a vital role in achieving its mission.

Analysts currently set an average price target of 234.56 USD for the Johnson & Johnson stock (median: 241.74 USD), implying -9.5 % versus the latest price. The consensus is based on 32 analyst ratings.

Johnson & Johnson 애널리스트 목표주가 2026

32 analysts currently rate the Johnson & Johnson stock: 19 recommend buying, 13 holding and 0 selling. For 2026, analysts expect Johnson & Johnson to generate revenue of 101.27 십억 USD and earnings per share of 11.64 USD.

Johnson & Johnson 애널리스트 목표주가 2026

Converted at the current exchange rate, the Johnson & Johnson share trades at 224.50 EUR (259.26 USD).

The Johnson & Johnson share (JNJ) is listed on 12 stock exchanges, including: NYSE (JNJ), XETRA (JNJ.DE), Frankfurt (JNJ.F), München (JNJ.MU), Stuttgart (JNJ.SG), Düsseldorf (JNJ.DU), Berlin (JNJ.BE), Hamburg (JNJ.HM).

Johnson & Johnson is one of the largest healthcare companies in the world. The company was founded in 1886 and is based in New Brunswick, New Jersey. With a wide portfolio of products and services, Johnson & Johnson is active in the consumer goods, medical technology, and pharmaceutical sectors. Consumer Goods: Johnson & Johnson is best known for its baby care products, such as diapers and wipes. The company also offers a wide range of other products, including personal care, wound healing, and pain relief products. Medical Technology: As a global leader in medical devices and instruments, Johnson & Johnson provides solutions for various areas of the medical field. In orthopedics, for example, the company offers implants for a variety of joints and bones. In medical imaging, Johnson & Johnson has a diverse range of devices that can be used for diagnosis and treatment. Pharmaceuticals: Johnson & Johnson is also active in the pharmaceutical business. The company is a global leader in the development and marketing of prescription drugs. In the field of oncology, for example, Johnson & Johnson offers various medications for the treatment of cancer. The company is also involved in neurology and immunology, offering a wide range of medications. Innovative Technologies: Johnson & Johnson heavily invests in innovative technologies to improve treatment options for patients. Examples of this include the "CaringCrowd" crowdfunding platform and the "Janssen Health EMEA Innovation Center," a platform for start-ups and companies focusing on groundbreaking innovations in healthcare. Research and Development: Research and development is a crucial aspect of Johnson & Johnson's business success. The company invests significant amounts each year in the research and development of new products and technologies. The goal is to develop products that meet the needs of patients and address various diseases and conditions. Johnson & Johnson also conducts extensive clinical studies to ensure the safety and efficacy of its products. Conclusion: Johnson & Johnson has a diverse range of products and services. The company is a leading provider in consumer goods, medical technology, and pharmaceuticals. It heavily invests in innovative technologies and research and development to offer treatment options to patients worldwide that meet the highest standards in terms of efficacy and safety. The output answer: Johnson & Johnson is a global healthcare company that offers a wide range of consumer goods, medical technology, and pharmaceutical products. It invests in innovative technologies and research and development to provide effective and safe treatment options for patients worldwide.

예상의 Johnson & Johnson 매출은 101.27 십억 USD입니다. 이 수치는 최신 재무 데이터를 기반으로 하며 회사의 경영 성과를 반영합니다.

예상의 Johnson & Johnson 이익은 28.38 십억 USD입니다. 순이익은 모든 비용을 공제한 후 회사의 수익성을 반영합니다.

Johnson & Johnson의 주가수익비율(PER)은 현재 22.28입니다. PER은 현재 주가를 주당순이익과 비교하여 Johnson & Johnson 주식의 가치평가를 평가하는 데 도움을 줍니다.

Johnson & Johnson의 주가매출비율(PSR)은 현재 6.24입니다. PSR은 시장 자본금을 연간 수익으로 비교하며 Johnson & Johnson 주식의 가치평가 지표로 사용됩니다.

Johnson & Johnson의 Eulerpool 품질 점수는 6/10입니다.

Johnson & Johnson의 ISIN은 US4781601046입니다. ISIN(국제증권식별번호)은 증권을 식별하기 위한 전 세계 고유 식별자입니다.

Johnson & Johnson의 WKN은 853260입니다. WKN(Wertpapierkennnummer)은 증권을 식별하기 위한 6자리 독일 증권 식별 번호입니다.

Johnson & Johnson의 티커는 JNJ입니다. 티커 기호는 증권거래소에서 Johnson & Johnson 주식을 거래하는 데 사용됩니다.

지난 12개월 동안 Johnson & Johnson는 5.14 USD 의 배당금을 지급했습니다. 이는 약 1.98 %의 배당수익률에 해당합니다. 향후 12개월 동안 Johnson & Johnson는 5.56 USD의 배당금을 지급할 것으로 예상됩니다.

Johnson & Johnson의 현재 배당 수익률은 1.98 %입니다.

Johnson & Johnson는 배당금을 지급하며, , , , 개월에 분배됩니다.

Johnson & Johnson는 지난 62년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 5.56 USD의 배당금이 예상됩니다. 이는 2.16 %의 배당수익률에 해당합니다.

Johnson & Johnson는 '건강' 섹터로 분류됩니다.

2025년에 Johnson & Johnson는 배당금으로 4.91 USD를 분배했습니다.

Johnson & Johnson의 배당금은 USD로 분배됩니다.